SCHEMBL3674930

SCHEMBL3674930

COc1cccc(C(CNC2=NCCO2)c2cccnc2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 1/20 0.45
ADRA2A P08913 1/20 0.43
ADRA1A P35348 1/20 0.43
THRB P10828 1/20 0.41
ALDH1A1 P00352 4/20 0.40
PDE4D Q08499 1/20 0.38
TSHR P16473 2/20 0.37
HSD17B10 Q99714 2/20 0.37
ALOX15 P16050 1/20 0.37
KMT2A Q03164 2/20 0.37
AOC3 Q16853 1/20 0.37
TAAR1 Q96RJ0 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
ROCK2 O75116 1/20 0.36
GAA P10253 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3673071 0.88 ADRA2A (0.47) KCNA5ADRA2AADRA1ATHRBAOC3
SCHEMBL3666286 0.85 SLC6A3 (0.43) KCNA5ADRA2AALDH1A1HSD17B10CYP3A4
SCHEMBL1157346 0.79 ADRA2A (0.42) KCNA5ADRA2AADRA1AALDH1A1TSHR
SCHEMBL3674513 0.77 P2RX7 (0.42) KCNA5THRBALDH1A1CYP2D6GAA
Ammonia Solution, Strong SCHEMBL6000232 0.74 KCNA5 (0.56) KCNA5PDE4DTSHRKMT2ACYP1A2
SCHEMBL3414027 0.72 CFB (0.39) ADRA2AAOC3TAAR1
SCHEMBL3672607 0.71 P2RX7 (0.35) KCNA5ADRA2ATAAR1CYP3A4CYP2D6
SCHEMBL3415420 0.70 ADRA2A (0.41) ADRA2AADRA1ATHRBAOC3TAAR1
SCHEMBL3414425 0.70 TAAR1 (0.44) ADRA2AADRA1AAOC3TAAR1CYP3A4
SCHEMBL1157345 0.70 ADRA2A (0.46) ADRA2AADRA1AAOC3TAAR1ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2242753-A1 OXAZOLIDINE AND THIAZOLIDINE SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THEREOF ALLERGAN, INC. (US) 2010-10-27 EP disclosed
EP-2240468-A1 SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THEREOF ALLERGAN, INC. (US) 2010-10-20 EP disclosed
WO-2009091760-A1 OXAZOLIDINE AND THIAZOLIDINE SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THEREOF ALLERGAN, INC. (US) 2009-07-23 WO disclosed
WO-2009091759-A1 SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THEREOF ALLERGAN, INC. (US) 2009-07-23 WO disclosed